What is Blue Longevity?
Blue Longevity functions as an international preventive health and longevity platform, integrating scientific research, lifestyle optimization, and cutting-edge technology. By synthesizing evidence-based therapies with personalized health plans, the company addresses the growing market demand for proactive health management. Its core value proposition lies in its ability to translate complex biological data into actionable insights, thereby fostering resilience and facilitating meaningful life extension for its global user base. The company occupies a unique niche in the health-tech ecosystem, bridging the gap between clinical diagnostics and consumer-facing wellness solutions.
How much funding has Blue Longevity raised?
Blue Longevity has raised a total of $2.3M across 1 funding round:
Unspecified
$2.3M
Unspecified (2025): $2.3M with participation from Sofia Angels Ventures and Eleven Ventures
Key Investors in Blue Longevity
Sofia Angels Ventures
Sofia Angels Ventures is a co-investment venture capital fund focusing on early-stage technology startups, particularly in the MedTech and Greentech sectors, supported by the European Investment Fund.
Eleven Ventures
Eleven Ventures is a prominent investment firm based in Sofia, Bulgaria, specializing in supporting scalable startups and providing strategic guidance to emerging companies.
What's next for Blue Longevity?
With this major strategic investment, Blue Longevity is well-positioned to accelerate its research and development initiatives, particularly in the realm of personalized longevity protocols. The capital will likely be deployed to scale its diagnostic infrastructure and expand its international footprint, ensuring that its evidence-based therapies reach a broader demographic. As the company transitions into this next phase of growth, the focus will remain on refining its proprietary algorithms and strengthening its clinical partnerships. By leveraging this financial backing, Blue Longevity aims to solidify its market leadership, setting a new standard for how technology can be utilized to optimize human healthspan and mitigate age-related decline.
See full Blue Longevity company page
